Document Detail

Intravenous streptokinase and percutaneous transluminal coronary angioplasty in acute myocardial infarction.
MedLine Citation:
PMID:  2963686     Owner:  NLM     Status:  MEDLINE    
Intravenous streptokinase already has been demonstrated safe and beneficial in acute myocardial infarction. The adjunction of early angiography seems to be safe, providing the possibility of full revascularization in a larger number of patients with a high rate of primary success. The improvement of global ventricular function, the reduction of mortality, post infarction angina and reocclusion have to be confirmed by longer follow-up.
R Bonan
Related Documents :
9115526 - Magnesium sulfate therapy in certain emergency conditions.
4045046 - High dose intravenous streptokinase for acute myocardial infarction: preliminary result...
6358886 - Western washington randomized trial of intracoronary streptokinase in acute myocardial ...
2963686 - Intravenous streptokinase and percutaneous transluminal coronary angioplasty in acute m...
2739416 - Tricuspid valve repair. operative and follow-up evaluation by doppler color flow mapping.
14607436 - Association of cardiac troponin, ck-mb, and postoperative myocardial ischemia with long...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  The Canadian journal of cardiology     Volume:  3 Suppl A     ISSN:  0828-282X     ISO Abbreviation:  Can J Cardiol     Publication Date:  1987 Nov 
Date Detail:
Created Date:  1988-04-07     Completed Date:  1988-04-07     Revised Date:  2008-04-09    
Medline Journal Info:
Nlm Unique ID:  8510280     Medline TA:  Can J Cardiol     Country:  CANADA    
Other Details:
Languages:  eng     Pagination:  30A-33A     Citation Subset:  IM    
Cardiac Catherterization Laboratory, Montreal Heart Institute, Quebec.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angioplasty, Balloon*
Clinical Trials as Topic
Infusions, Intravenous
Myocardial Infarction / drug therapy,  mortality,  therapy*
Random Allocation
Streptokinase / therapeutic use*
Time Factors
Reg. No./Substance:
EC 3.4.-/Streptokinase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  On a factor present in tumor cells, capable of decreasing thermotolerance in mice
Next Document:  B-cell lineage acute lymphoblastic leukemia with i(7q) and t(9;9)(p22;p24).